News

AACR: KEYNOTE-001 takes step toward PD-L1 blocker biomarker

Publish date: April 23, 2015

 

FROM THE AACR ANNUAL MEETING

References

pwendling@frontlinemedcom.com

On Twitter @pwendl

Pages

Recommended Reading

Medicare advisers: Cancer prognostic tests not ready for prime time
MDedge Hematology and Oncology
Palliative surgery eases pain at end of life
MDedge Hematology and Oncology
No significant survival gains with granulocyte colony-stimulating factor
MDedge Hematology and Oncology
Sleep disorders in patients with cancer
MDedge Hematology and Oncology
VIDEO: TKIs merit broader use as NSCLC adjuvant
MDedge Hematology and Oncology
Advanced NSCLC responds to nivolumab
MDedge Hematology and Oncology
TKI benefit greater with certain EGFR mutations in NSCLC tumors
MDedge Hematology and Oncology
VIDEO: Circulating tumor DNA testing shows real-world limits
MDedge Hematology and Oncology
Three-dimensional models show superiority of nanoparticles in mesothelioma
MDedge Hematology and Oncology
Sarcoidosis, complete heart block, and warm autoimmune hemolytic anemia in a young woman
MDedge Hematology and Oncology